| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84781 |
CAS号：2055024-65-0 ，Azido-PEG3-Val-Cit-PAB-OH |
144 |
WYQ |
2024-12-18 |
| 84782 |
DOTA-CCK-66 大环DOTA偶联CCK2R靶向化合物CCK-66 |
508 |
h |
2024-12-18 |
| 84783 |
cas:1228153-04-5，4-Formyl-N-(2-(naphthalen-2-yloxy)ethyl)benzamide |
157 |
kx |
2024-12-18 |
| 84784 |
抗DOTA IgG-scFv BsAb anti-DOTA IgG-scFv BsAb |
223 |
h |
2024-12-18 |
| 84785 |
cas:1226217-30-6，4-Formyl-N-(2-(4-isopropylphenoxy)ethyl)benzamide |
159 |
kx |
2024-12-18 |
| 84786 |
DOTA-rL-A9肽 DOTA偶联核定位序列(NLS)-移植的her 2-受体亲和肽 |
197 |
h |
2024-12-18 |
| 84787 |
cas:796073-59-1，2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
120 |
kx |
2024-12-18 |
| 84788 |
DOTA-E[c(RGDFK)]2 双功能螯合剂偶联的RGD多肽E[c(RGDfK)]2 |
127 |
h |
2024-12-18 |
| 84789 |
DBCO-C4-Val-Cit-PABC-PNP，分子式：C46H49N7O10 |
141 |
WYQ |
2024-12-18 |
| 84790 |
DBCO-(PEG)3-VC-PAB-MMAE，CAS号：57103-68-1 |
99 |
WYQ |
2024-12-18 |
| 84791 |
cas:1134280-65-1，2,5-Dioxopyrrolidin-1-yl 3-((2,4-difluorobenzyl)oxy)propanoate |
125 |
kx |
2024-12-18 |
| 84792 |
DBCO-PEG3-acetic-Val-Cit-PAB（二苯并环辛炔） |
145 |
WYQ |
2024-12-18 |
| 84793 |
cas:1824718-79-7，SPDH， ADC试剂 |
132 |
kx |
2024-12-18 |
| 84794 |
cas:1232769-29-7，2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate |
130 |
kx |
2024-12-18 |
| 84795 |
Amino-PEG2-VG-N-Bis(PEG1-azide)，氨基-二聚乙二醇-VG-N-双（一聚乙二醇-叠氮） |
176 |
WYQ |
2024-12-18 |
| 84796 |
Alkyne-Val-Cit-PAB-FAM，炔-VAL-CIT-PAB-FAM |
127 |
WYQ |
2024-12-18 |
| 84797 |
cas:1226218-43-4，4-Formyl-N-(2-(2,3,6-trimethylphenoxy)ethyl)benzamide |
132 |
kx |
2024-12-18 |
| 84798 |
双功能螫合剂DOTA偶联MAG3 DOTA-MAG3 |
161 |
h |
2024-12-18 |
| 84799 |
Alkyne-Val-Cit-PAB-PNP，炔-Val-Cit-PAB-PNP |
135 |
WYQ |
2024-12-18 |
| 84800 |
DOTA-MSH2 金属螯合剂DOTA偶联二聚体肽(MSH2) |
144 |
h |
2024-12-18 |
| 84801 |
cas:796073-64-8，(S)-2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
122 |
kx |
2024-12-18 |
| 84802 |
N,N-二乙基正辛硫基乙酰胺,(N,N-Diethyl-α-(OctlyThio)-Acetamide)简称DOTA |
157 |
h |
2024-12-18 |
| 84803 |
cas:437655-95-3，Fmoc-NH-PEG4-CH2COOH， 5,8,11,14-四氧杂-2-氮杂十六碳二酸 1-芴甲基酯 |
145 |
kx |
2024-12-18 |
| 84804 |
Val-Ala-PAB-OH |
165 |
zyl |
2024-12-18 |
| 84805 |
DOTA-Bz-Cys-RGD dimer 双功能螯合剂修饰Cys-RGD dimer |
138 |
h |
2024-12-18 |
| 84806 |
cas:874208-92-1，m-PEG7-NHS ester， ADC试剂 |
137 |
kx |
2024-12-18 |
| 84807 |
Boc-PEG4-Val-Ala-PAB-PNP |
131 |
zyl |
2024-12-18 |
| 84808 |
111 In-奥曲肽(Octreo Scan) |
660 |
h |
2024-12-18 |
| 84809 |
POSS-DOTA 大环配体DOTA偶联七异丁基-氨丙基六面体倍半硅氧烷POSS |
163 |
h |
2024-12-18 |
| 84810 |
cas:164332-88-1，N-Boc-PEG1-bromide， [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
132 |
kx |
2024-12-18 |
| 84811 |
DOTA-Substance P DOTA-SP |
183 |
h |
2024-12-18 |
| 84812 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
144 |
zyl |
2024-12-18 |
| 84813 |
FITC-Gly-Gly-Gly-CBT |
138 |
h |
2024-12-18 |
| 84814 |
FITC-Gly-Gly-Gly-CBT |
192 |
h |
2024-12-18 |
| 84815 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne，荧光素类染料的一种 |
204 |
WYQ |
2024-12-18 |
| 84816 |
cas:98604-88-7，Bis-SS-C3-NHS ester， ADC试剂 |
163 |
kx |
2024-12-18 |
| 84817 |
DOTA-钆特酸葡甲胺 Gd-DOTA |
251 |
h |
2024-12-18 |
| 84818 |
MAL-tri-EG-OPFP的介绍 |
185 |
zyl |
2024-12-18 |
| 84819 |
NH2-PEG-NH2 氨基-聚乙二醇-氨基 |
188 |
h |
2024-12-18 |
| 84820 |
cas:1884578-00-0，Boc-Val-Ala-PAB-PNP |
148 |
kx |
2024-12-18 |
| 84821 |
CAS号为1613321-01-9的6-Azidohexanoyl-Val-Cit-PAB |
151 |
WYQ |
2024-12-18 |
| 84822 |
聚乙二醇PEG-DOTA修饰超支化聚乙烯亚胺 PEI-PEG-DOTA |
178 |
h |
2024-12-18 |
| 84823 |
DOTA修饰奥曲肽 DOTA-octreotide |
157 |
h |
2024-12-18 |
| 84824 |
CAS号为644981-35-1的Val-Cit-PAB-MMAE |
136 |
WYQ |
2024-12-18 |
| 84825 |
DOTA-KEK-(GX1)2 DOTA修饰GX1的二聚体 |
183 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询